NCT02955810View on ClinicalTrials.gov

Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA)

PHASE1UnknownINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

November 30, 2020

Conditions

Multiple Myeloma

Interventions

DRUG

Daratumumab

DRUG

Cyclophosphamide

DRUG

Bortezomib

DRUG

Dexamethasone

Trial Locations (1)

Unknown

Galway University Hospital, Galway

Sponsors

Collaborators (1)

Janssen Pharmaceuticals

All Listed Sponsors

collaborator

Janssen Pharmaceuticals

INDUSTRY

collaborator

Cancer Trials Ireland

NETWORK

lead

National University of Ireland, Galway, Ireland

OTHER